Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-22Clinical Trial Update: Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab [Phase 3]
A Phase 3 randomized trial comparing bendamustine plus rituximab versus fludarabine plus rituximab in non-Hodgkin's lymphoma and mantle cell…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma [Phase 2]
This document provides an update on a Phase 2 clinical trial of CD19-targeted CAR T cells for relapsed or refractory large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) [Phase 1]
The ENABLE-1 Phase 1 trial investigates Toll-like receptor signaling to enhance B-cell lymphoma CAR-T therapy, with the study currently list…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating lisocabtagene maraleucel (JCAR017) in pediatric relapsed/refractory B-cell acute lymphoblastic leukemi…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SGI-1776, a PIM kinase inhibitor, in refractory prostate cancer and relapsed/refractory non-Hodgkin lymphoma was terminated…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165 [Phase 2]
This Phase 2 trial update reports long-term follow-up data and thalidomide maintenance outcomes for patients enrolled in Clinical Trial 2003…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Study of AXT-1003 in Adult Subjects With Relapsed/Refractory Non-Hodgkin Lymphomas [Phase 1]
The Phase 1 study of AXT-1003 in adults with relapsed or refractory Non-Hodgkin lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: The clonoSEQ® Watch Registry
Clinical trial update for the clonoSEQ Watch Registry sponsored by Adaptive Biotechnologies; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Dose Escalation Study Evaluating the Safety and Tolerability of GDC-0032 in Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma (NHL) and in Combination With Endocrine Therapy in Locally Advanced or Metastatic Hormone Receptor-Positive Breast Cancer [Phase 1]
This Phase 1 dose-escalation trial of taselisib (GDC-0032) in locally advanced or metastatic solid tumors or Non-Hodgkin lymphoma, including…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating Imvotamab monotherapy and in combination for relapsed/refractory non-Hodgkin lymphoma has been terminated…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma [Phase 3]
Phase 3 trial update for tisagenlecleucel in adults with aggressive B-cell non-Hodgkin lymphoma has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression [Phase 3]
Phase 3 trial evaluating haploidentical allogeneic peripheral blood transplantation with analysis of checkpoint immune regulator expression;…
-
CLINICAL_TRIALS trial_result · 2024-07-19Clinical Trial Update: Study of TG-1701, an Irreversible Bruton's Tyrosine Kinase Inhibitor, in Patients With B-Cell Malignancies [Phase 1]
Clinical Trial Update reports the termination of a Phase 1 study of TG-1701 in B-cell malignancies.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders [Phase 1]
Phase 1 trial update on T-allo10 for hematopoietic stem cell transplantation in various blood disorders; the NCT03198234 study sponsored by …
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia) [Phase 2]
Phase 2 clinical trial update on LOXO-305 (pirtobrutinib) in Chinese participants with B-cell malignancies, with results posted on July 16, …
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers [NA]
This clinical trial update indicates the study evaluating cardiac rehabilitation for patients receiving radiation therapy for thoracic cance…
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma [Phase 1]
DCR-MYC, an investigational therapy, was evaluated in a Phase I multicenter dose-escalation study in patients with solid tumors, multiple my…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide [Phase 2]
Phase 2 haploidentical stem cell transplantation trial using post-transplant cyclophosphamide was terminated.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL [Phase 1]
Phase 1 trial results for FT596 CAR-T cells with Rituximab as relapse prevention after autologous HSCT in non-Hodgkin lymphoma were posted, …
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies [Phase 1, Phase 2]
GIC-102, an intravenously administered allogeneic NK cell therapy, is being evaluated in Phase 1/Phase 2 trials for advanced solid tumors an…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: CD34+ Selected ASCT for Aggressive Lymphomas [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating CD34+ selected autologous stem cell transplantation for aggressive…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001) [Phase 1]
Phase 1 study evaluating safety and pharmacokinetics of JCAR017 in B-cell non-Hodgkin lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 study evaluating TAK-981 plus rituximab in adults with relapsed or refractory CD20-positive non-Hodgkin lymphoma was terminated,…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies [Phase 1]
Phase 1 study of STRO-001, an anti-CD74 antibody-drug conjugate, in advanced B-cell malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
This is a Phase 1 study update for CC-97540, a CD19-targeted NEX-T CAR T cell therapy, in relapsed or refractory B-cell non-Hodgkin lymphoma…